Spray Cryotherapy for the Management of Benign Central Airway Stenosis (Cryo-BAS)

Recruiting Phase 2 Interventional Study
Stenosis of Trachea
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Beth Israel Deaconess Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to compare spray cryotherapy plus balloon dilatation versus current standard of Care (SoC - steroid injection, radial cuts and balloon dilatation) in patients with benign airway stenosis with simple stenosis. The main question\[s\] investigators aim to answer are: 1. What is the need for reintervention and time to reintervention in participants with benign airwa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 1\. Patients with symptomatic, benign, simple stenosis of the trachea and/or subglottic space. * 2\. Stenotic airway of diameter \< 1cm. Exclusion Criteria: 1. Complex stenosis, cartilage involvement (malacia or fracture). 2. Patients with giant bullae (\> a third of hemitho…
Contacts

Christine Conley

617-632-8386

Cconley@bidmc.harvard.edu

CONTACT